Literature DB >> 15953013

Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene.

Elisa Fermo1, Paola Bianchi, Laurent R Chiarelli, Frederic Cotton, Cristina Vercellati, Karin Writzl, Kerry Baker, Ian Hann, Robin Rodwell, Giovanna Valentini, Alberto Zanella.   

Abstract

The PK-LR gene was studied in 23 patients with congenital haemolytic anaemia associated with erythrocyte pyruvate kinase (PK) deficiency. Twenty-seven different mutations were detected among the 42 mutated alleles identified: 19 missense mutations, four splice site mutations and one nonsense, one single base deletion and two large deletions. Seventeen of them (107G, 278T, 403T, 409A, 661A, 859C, 958A, 1094T, 1190T, 1209A, 1232C, 1369G, 507A, IVS9 -1c, IVS9 +43c [corrected] del C224, del 5006bp IVS3--> nt 1431) were new. Although all the exons, the flanking regions and the promoter were sequenced in all cases, we failed to detect the second expected mutation in four subjects. To correlate genotype to phenotype, the molecular results were related to the biochemical properties of the mutant enzymes by an analysis of the three-dimensional structure of erythrocyte PK. The new mutant 409A, found in association with the large deletion of 5006 bp in a newborn baby who died soon after birth, was functionally characterized by mutagenesis and in vitro expression of the protein to investigate its contribution in the severity of the clinical pattern. However, the biochemical data obtained for the mutant enzyme cannot explain the severe anaemia found in the PK-deficient patient hemizygous for this mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953013     DOI: 10.1111/j.1365-2141.2005.05520.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and seconday hemochromatosis in dogs.

Authors:  G Inal Gultekin; K Raj; P Foureman; S Lehman; K Manhart; O Abdulmalik; U Giger
Journal:  J Vet Intern Med       Date:  2012 Jul-Aug       Impact factor: 3.333

2.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

Review 3.  Laboratory Approach to Hemolytic Anemia.

Authors:  Manu Jamwal; Prashant Sharma; Reena Das
Journal:  Indian J Pediatr       Date:  2019-12-10       Impact factor: 1.967

4.  Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases.

Authors:  Yanqiu Liu; Xiaoming Wei; Xiangdong Kong; Xueqin Guo; Yan Sun; Jianfen Man; Lique Du; Hui Zhu; Zelan Qu; Ping Tian; Bing Mao; Yun Yang
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Novel mutations associated with pyruvate kinase deficiency in Brazil.

Authors:  Maria Carolina Costa Melo Svidnicki; Andrey Santos; Jhonathan Angel Araujo Fernandez; Ana Paula Hitomi Yokoyama; Isis Quezado Magalhães; Vitoria Regia Pereira Pinheiro; Silvia Regina Brandalise; Paulo Augusto Achucarro Silveira; Fernando Ferreira Costa; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2017-11-26

6.  Erythrocyte pyruvate kinase deficiency mutation identified in multiple breeds of domestic cats.

Authors:  Robert A Grahn; Jennifer C Grahn; Maria Ct Penedo; Chris R Helps; Leslie A Lyons
Journal:  BMC Vet Res       Date:  2012-10-30       Impact factor: 2.741

Review 7.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

8.  Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Authors:  Zita Garate; Oscar Quintana-Bustamante; Ana M Crane; Emmanuel Olivier; Laurent Poirot; Roman Galetto; Penelope Kosinski; Collin Hill; Charles Kung; Xabi Agirre; Israel Orman; Laura Cerrato; Omaira Alberquilla; Fatima Rodriguez-Fornes; Noemi Fusaki; Felix Garcia-Sanchez; Tabita M Maia; Maria L Ribeiro; Julian Sevilla; Felipe Prosper; Shengfang Jin; Joanne Mountford; Guillermo Guenechea; Agnes Gouble; Juan A Bueren; Brian R Davis; Jose C Segovia
Journal:  Stem Cell Reports       Date:  2015-11-05       Impact factor: 7.765

9.  Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.

Authors:  Rebekah van Bruggen; Christian Gualtieri; Alexandra Iliescu; Chalisa Louicharoen Cheepsunthorn; Punchalee Mungkalasut; Jean-François Trape; David Modiano; Bienvenu Sodiomon Sirima; Pratap Singhasivanon; Mark Lathrop; Anavaj Sakuntabhai; Jean-François Bureau; Philippe Gros
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

Review 10.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.